NEW YORK -- The world market for products to treat burn wounds stands at more than $1.5 billion and will surpass the $2 billion mark in the next few years, according to a new study released today from Kalorama Information. Leading the growth in burn care are several market segments, including silver dressings and portions of the biological dressings sector, both of which will display annual growth in excess of 20 percent through the end of the decade.
The new study, Wound Care Markets, Volume II: Burns, found that after a few years of slowing momentum, the burn-care segment has begun to stabilize. However, emerging technologies and approaches to burn care will continue to push the dynamic market forward.
"After a decline in growth in 2000, the market appears to be settling," notes Mary Anne Crandall, the author of the report. "However, burn care will continue to experience a few ups and downs due to price constraints, new technologies, and additional market penetration by emerging therapeutics."
The study examines six broad categories of products-anti-infectives, burn management products, moist dressings, biological dressings, pressure relief devices, and other miscellaneous treatments-and more than 10 subcategories, including cleansers, debridement products, silver dressings, alginates, films, foams, hydrocolloids, hydrogels, artificial skins, collagen products, and others.
In addition to a thorough analysis of market size and growth through 2009 for each segment and subsegment, the study details competitive market share in each segment and provides a thorough understanding of the clinical and reimbursement environment in which these wound care manufacturers operate.
Source: Kalorama Information, a division of MarketResearch.com
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.